Annexon (ANNX) Enterprise Value (2020 - 2026)
Annexon (ANNX) posted quarterly Enterprise Value of -$225.0 million for Q1 2026, up 15.0% year-over-year from -$195.7 million in Q1 2025, and up 4.78% quarter-over-quarter from -$236.3 million in Q4 2025.
Analysis
Annexon (ANNX) Enterprise Value (2020 - 2026) Analysis & Trends
Annexon's Enterprise Value history runs 8 years deep, the most recent figure standing at -$225.0 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 15.0% year-over-year to -$225.0 million; the TTM figure through Mar 2026 stood at -$225.0 million (up 15.0% YoY), while the FY2025 annual figure was -$236.3 million, up 24.51% from the prior year.
- Enterprise Value for Q1 2026 stood at -$225.0 million, up from -$236.3 million in the prior quarter.
- The five-year high for Enterprise Value was -$94.4 million in Q1 2022, with the low at -$369.7 million in Q2 2024.
- The 5-year median for Enterprise Value is -$236.3 million (2025), against an average of -$239.4 million.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value soared 71.1% in 2022, then sank 142.76% in 2023.
- Annexon's Enterprise Value stood at -$243.7 million in 2022, then declined by 7.0% to -$260.7 million in 2023, then retreated by 20.06% to -$313.0 million in 2024, then rose by 24.51% to -$236.3 million in 2025, then grew by 4.78% to -$225.0 million in 2026.
- Business Quant data shows ANNX's Enterprise Value at -$225.0 million in Q1 2026, -$236.3 million in Q4 2025, and -$188.7 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Annexon | 982.93 Mn | 982.93 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 787.75 Mn |
| Mar 31, 2026 | 675.23 Mn |
| Dec 31, 2025 | 511.46 Mn |
| Sep 30, 2025 | 266.11 Mn |
| Jun 30, 2025 | 127.92 Mn |
| Mar 31, 2025 | 21.12 Mn |
| Dec 31, 2024 | 391.83 Mn |
| Sep 30, 2024 | 487.26 Mn |
| Jun 30, 2024 | 147.41 Mn |
| Mar 31, 2024 | 613.59 Mn |
| Dec 31, 2023 | 95.05 Mn |
| Sep 30, 2023 | 11.51 Mn |
| Jun 30, 2023 | 70.84 Mn |
| Mar 31, 2023 | 55.15 Mn |
| Dec 31, 2022 | 3.04 Mn |
| Sep 30, 2022 | 153.72 Mn |
| Jun 30, 2022 | -33.09 Mn |
| Mar 31, 2022 | -101.38 Mn |
| Dec 31, 2021 | 199.18 Mn |
| Sep 30, 2021 | 442.79 Mn |